RecruitingNot applicableNCT05977088

Prediction of Effectiveness of rTMS Application in Alzheimer's Patients

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Istanbul Medipol University Hospital
Principal Investigator
Lutfu Hanoglu, Prof. DR. MD
Medipol University
Intervention
Repetetive Transcranial Magnetic Stimulation(device)
Enrollment
40 enrolled
Eligibility
55 years · All sexes
Timeline
2022 – 2025

Study locations (1)

Collaborators

Bezmialem Vakif University · Saglik Bilimleri Universitesi

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05977088 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials